CLICHY, France–(BUSINESS WIRE)–CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD). The results were presented at the 46th Annual Conference of the European Society for Artificial Organs (ESAO) in Hannover. Trevor […]
Tag: CorWave
CorWave to Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device
CLICHY, France–(BUSINESS WIRE)–CorWave announced today that results from chronic preclinical studies to evaluate its Left Ventricular Assist Device (LVAD) will be presented at the 65th Annual Conference of the American Society for Artificial Internal Organs (ASAIO) in San Francisco. The […]
CorWave’s Next-Generation LVAD, Neptune, Receives Funding
CLICHY, France–(BUSINESS WIRE)–The CALYPSO Research and Development (R&D) program, with a total budget of 25 million euros over 4 years, will be partially financed with 14 million euros support from the Programme d’Investissements d’Avenir (Future Investments Program), managed by the Secrétariat Général […]
CorWave is Set to Receive about $3.5 Million in Financing Through France’s Worldwide Innovation Challenge for Its NovaPulse Program, a Mini-Invasive Solution for Cardiac Support
CLICHY, France–(BUSINESS WIRE) CorWave, a French medical technology company that develops innovative implanted cardiac support devices for patients suffering from heart failure, announced today that it has been awarded almost $3.5 million in financing for its R&D program NovaPulse in […]